AF
ALXN

Allworth Financial’s Alexion Pharmaceuticals ALXN Stock Holding History

Allworth Financial’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50
Closed -$5K – 1135
2019
Q3 		$5K Hold
50
– – ﹤0.01% 698
2019
Q2 		$7K Hold
50
– – ﹤0.01% 643
2019
Q1 		$7K Hold
50
– – ﹤0.01% 633
2018
Q4 		$5K Hold
50
– – ﹤0.01% 627
2018
Q3 		$7K Hold
50
– – ﹤0.01% 614
2018
Q2 		$6K Buy
+50
New +$5.84K ﹤0.01% 613
2017
Q2 		– Sell
-160
Closed -$19K – 842
2017
Q1 		$19K Hold
160
– – ﹤0.01% 373
2016
Q4 		$18K Hold
160
– – ﹤0.01% 338
2016
Q3 		$20K Hold
160
– – ﹤0.01% 332
2016
Q2 		$19K Buy
+160
New +$22.7K ﹤0.01% 318

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Allworth Financial's ALXN Position: Q4 2019 in Review

Allworth Financial sold out of Alexion Pharmaceuticals (ALXN) in Q4 2019, closing a stake of 50 shares — an estimated $5K sold.

Allworth Financial first reported a position in ALXN in Q2 2016 and held it in 10 quarters. The position peaked at $20K in Q3 2016. 669 funds tracked by Wall St. Rank hold ALXN as of Q4 2019.

  • Allworth Financial reported no remaining Alexion Pharmaceuticals position as of Q4 2019 after selling out during the quarter.
  • Allworth Financial sold 50 Alexion Pharmaceuticals shares in Q4 2019, an estimated $5K.
  • Allworth Financial first reported a position in Alexion Pharmaceuticals in Q2 2016 and held it in 10 quarters.
  • Allworth Financial's Alexion Pharmaceuticals position peaked at $20K in Q3 2016.
  • 669 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2019.

Based on Allworth Financial's 13F filing for Q4 2019, filed 16 Jan 2020.